These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
7. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine. Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy: how to influence an important risk factor in hypertension. Agabiti-Rosei E; Muiesan ML J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524 [TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive therapies on the sympathetic nervous system. de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass. Myers MG; Leenen FH; Tanner J Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497 [TBL] [Abstract][Full Text] [Related]
12. Efficient inhibition of the development of cardiac remodeling by a long-acting calcium antagonist amlodipine. Yamazaki T; Komuro I; Zou Y; Kudoh S; Shiojima I; Mizuno T; Hiroi Y; Nagai R; Yazaki Y Hypertension; 1998 Jan; 31(1):32-8. PubMed ID: 9449387 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment. Novo S; Abrignani MG; Corda M; Strano A Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619 [TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines. Leenen FH Am J Hypertens; 1996 Oct; 9(10 Pt 2):97S-104S; discussion 108S-109S. PubMed ID: 8896671 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects on blood pressure and left ventricular hypertrophy of lacidipine and hydrochlorothiazide in hypertensive patients. Leonetti G; Fogari R; Mazzola C; Mangiameli S; Castello C J Hypertens Suppl; 1991 Dec; 9(3):S29-31. PubMed ID: 1839161 [TBL] [Abstract][Full Text] [Related]
16. Relevance of 24 H blood pressure profile and sympathetic activity for outcome on short- versus long-acting 1,4-dihydropyridines. Ruzicka M; Leenen FH Am J Hypertens; 1996 Jan; 9(1):86-94. PubMed ID: 8834712 [TBL] [Abstract][Full Text] [Related]
17. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension. Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438 [TBL] [Abstract][Full Text] [Related]